Events and Presentations

Part of the work at Abliva consists of making the company’s activities visible in different public contexts, partly to increase understanding of the enormous medical needs of people with primary mitochondrial disease, but also to increase interest in the company among potential investors or partners.

Company and project presentations

View our latest company presentation in PDF here (February 2023)Download

BioStock Investor Meeting
16 March 2023

Aktiespararna’s Stora Aktiedagen Stockholm
29 November 2022

Aktiespararna’s Aktiedagen Lund
26 September 2022

Aktiespararna’s Temadag Life Science
31 August 2022

© 2022 Oroboros Instruments

Bioblast 2022, Innsbruck, Austria
29 – 30 June 2022

BioStock interview on SEK 200 million financing round
June 1, 2022

Open the presentation here: Presentation Mitochondria-Targeted Drug Development

Mitochondria-Targeted Drug Development
22 – 24 Feb 2022.

BioStock Life Science Summit
20 Oct 2021.

Aktiespararna: Kvinnokvällen (Women’s night) in Malmö
19 Oct 2021.

Aktiespararna: Kvinnokvällen (Women’s night) in Gothenburg
31 Aug 2021.

UMDF Mitochondrial Medicine symposium
June 2021

Redeye Investor Forum Online
20 May 2021.

Redeye Orphan Drugs Seminar
28 April 2021.

Aktiedagen digitalt Stockholm
16 March 2021.

BioStock Live
9 March 2021.

Swiss Nordic Bio 2021
10 – 11 Feb 2021.

Mitochondrial Medicine 2020
30 Nov – 2 Dec.

Redeye Life Science Day
26 Nov 2020.

BioStock Life Science Summit 17 Nov 2020.

Aktiespararna: Kvinnokvällen (Women’s night) in Gothenburg.
12 October 2020.

10th Italian Meeting on Mitochondrial Diseases, 9-10 October 2020.

Abliva’s Mitochondria Day
16 September 2020.

UMDF’s Power Surge
26 June 2020

Abliva Capital Markets Day
23 June 2020